Skip to main content
. Author manuscript; available in PMC: 2016 Mar 4.
Published in final edited form as: J Hosp Med. 2011 Oct 28;7(3):195–202. doi: 10.1002/jhm.942

TABLE 5.

Area Under the Receiver Operator Characteristic Curve for Guideline-Defined and Cohort-Developed Regression Models

Model Outcome Variable Predictive Variables aROC (95% CI) Model Comparison aROC Difference (95% CI) P Value
1 CAP-resistance Guideline-defined 0.630 (0.570, 0.691) 2–1 0.079   (0.018, 0.139)   0.011
2 CAP-resistance Cohort-developed 0.709 (0.650, 0.768)
3 MRSA Guideline-defined 0.638 (0.560, 0.712) 4–3 0.135   (0.057, 0.213) <0.001
4 MRSA Cohort-developed 0.773 (0.703, 0.844)
5 Pseudomonas aeruginosa Guideline-defined 0.680 (0.593, 0.768) 6–5 0.090 (−0.193, 0.193)   0.090
6 Pseudomonas aeruginosa Cohort-developed 0.770 (0.683, 0.857)
7 MRSA Cohort-developed from CAP-resistance model 0.755 (0.682, 0.828) 7–4 −0.018 (−0.067, 0.031)   0.467
8 Pseudomonas aeruginosa Cohort-developed from CAP-resistance model 0.755 (0.665, 0.845) 8–6 −0.015 (−0.079, 0.049)   0.650

Abbreviations: aROC, area under the receiver operator characteristic; CAP, community acquired pneumonia; CI, confidence interval; MRSA, methicillin-resistant Staphylococcus aureus.